Ikris Pharma International specializes in sourcing and supplying Reference Listed Drugs (RLDs) for pharmaceutical companies, CROs, and research sponsors across the globe. With precision sourcing, robust documentation, and global compliance, we enable seamless access to comparator drugs essential for bioequivalence studies, clinical trials, and product development.
Reference Listed Drugs (RLDs) are FDA-approved innovator medicines used as standards in bioequivalence testing for generics and biosimilars. These products play a critical role in:
Ikris Pharma International bridges the access gap by sourcing authentic, batch-certified RLDs from trusted global manufacturers. We ensure full compliance with all relevant regulations and logistics requirements.
1️⃣ Request & Product Identification:
Submit your requirement (INN/brand name, country of origin, pack size, quantity, and study type). Our global sourcing team finds the exact match from verified suppliers.
2️⃣ Quotation & Documentation:
We provide pricing, regulatory status, CoA availability, and shipping details. Special instructions (like stability studies or expiry window) are handled with care.
3️⃣ Regulatory & Customs Clearance:
We handle all CDSCO, DGFT, MOHFW, and international documentation for compliant delivery to your trial site or lab—seamlessly.
4️⃣ Verified Packing & Timely Delivery:
RLDs are dispatched under validated conditions—ambient, cold chain, or ultra-cold—as per study protocols. Global deliveries typically occur within 7–21 working days.
WHO
CDSCO
DGFT
MOHFW
US FDA
EMA
MHRA
ANVISA
TGA
PMDA
HSA